<DOC>
	<DOCNO>NCT03020706</DOCNO>
	<brief_summary>The purpose study evaluate effect magnesium sulphate neostigmine-induced reversal neuromuscular block rocuronium</brief_summary>
	<brief_title>Effect Magnesium Sulphate Neostigmine</brief_title>
	<detailed_description>Comparison reversa time neostigmine magnesium group control group</detailed_description>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<criteria>ASA status 1 2 patient undergoing surgery 60 min general anesthesia electrolyte abnormality medication aminoglycoside , antiepileptic drug , magnesium underweight obesity ( BMI &lt; 18.5 &gt; 30 ) renal insufficiency ( Cr &gt; 1.4 mg/dl ) AV block neuromuscular disease ( ex : Myathenia gravis )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>magnesium sulphate</keyword>
	<keyword>neostigmine</keyword>
</DOC>